Owlet, Inc.
Owlet, Inc. develops connected pediatric health devices and software for home use, centered on wearable infant monitors, a companion mobile app, and related digital services. The company sells its products in the United States and internationally through direct-to-consumer, retail, and healthcare distribution channels.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueFDA-cleared and internationally certified home monitoring devices for infants.
Combined hardware offerings such as Dream Duo and related home monitoring products.
Owlet360 recurring service that provides personalized health and sleep insights.
Replacement and add-on items including fabric socks and travel cases.
Customers
Owlet sells primarily to parents and caregivers of infants who want home-based monitoring, sleep information, and health-related insights. It also serves healthcare channels and medical communities that use its certified monitoring products in clinical-to-home care settings. Retail partners and digital buyers are important because the company relies on consumer demand, brand awareness, and repeat app engagement.
Buy Dream Sock, Dream Duo, and Owlet360 to monitor infant sleep and health at home.
Purchase through major retailers and online marketplaces for convenience and brand trust.
Use medically certified products in care pathways that bridge hospital and home.
Buy and distribute products in overseas markets where regulatory clearances enable sales.
Pay monthly for Owlet360 to access personalized pediatric health and sleep insights.
Strategy
Owlet’s strategy is to use its FDA-cleared and internationally certified monitoring products to build trust with parents and expand its connected pediatric health platform. The company is also extending its business model through Owlet360, which adds recurring subscription revenue and deepens engagement with its installed base. International expansion and healthcare-channel adoption are important because they broaden the addressable market beyond U.S. consumer retail.
More devices and app usage increase brand loyalty and data depth.
Recurring revenue can improve customer lifetime value and engagement.
Approvals unlock new markets and reduce reliance on the U.S. market.
Medical credibility can broaden use cases and support premium positioning.
Geography
Q1/2026Owlet is based in the United States and sells products domestically and in more than 30 countries. Its international footprint includes Canada, Australia, the United Kingdom, the European Union, and other markets where regulatory clearances support distribution. Geography matters because product approvals, channel mix, and local consumer adoption shape where the company can sell and how quickly it can expand.
Share of the revenue the company reports by geography.
Risks
Owlet depends on consumer demand, retail sell-through, and distributor performance, so inventory levels and customer payment behavior can materially affect results. The business also faces regulatory, privacy, and competitive risks because its products sit at the intersection of consumer electronics, medical devices, and digital health. As a smaller company with a limited operating history at scale, it may need external financing and must manage product, subscription, and channel execution carefully.
- Liquidity and financing riskImpact: CriticalLikelihood: High
The company may need additional capital to fund operations and growth.
Exposure: Business continuity and strategic flexibility
- Channel inventory and sell-through riskImpact: HighLikelihood: High
Revenue depends on retailer stocking decisions and end-demand.
Exposure: Product sales and quarterly revenue volatility
- Competition from larger and non-cleared rivalsImpact: HighLikelihood: High
Competitors may have more capital, broader portfolios, and reach.
Exposure - Distributor and retailer credit riskImpact: HighLikelihood: Medium
Sales are made through intermediaries that may delay or fail to pay.
Exposure: Accounts receivable and cash collections
- Regulatory and product clearance riskImpact: HighLikelihood: Medium
Medical-device style products require approvals and certifications.
Exposure - Privacy and marketing compliance riskImpact: MediumLikelihood: Medium
Digital acquisition depends on use of customer data and ad targeting.
Exposure: Customer acquisition and brand reputation
Accounting
Judgemental itemsDifferent performance obligations are recognized over different periods.
Impact: Affects revenue timing and quarterly comparability
Management estimates reductions to revenue based on history and contracts.
Impact: Affects net revenue and receivables
Owlet360 cash receipts may be recognized over the service period.
Impact: Affects revenue deferral and future revenue visibility
Hardware businesses must estimate obsolescence and warranty-related costs.
Impact: Affects cost of revenues and gross margin
Management has disclosed substantial doubt about continued operations within one year.
Impact: Affects liquidity analysis and financial statement interpretation
Similar listed companies
Publicly listed companies with a comparable business focus.
Insulet Corporation
PODD · Surgical & Medical Instruments & Apparatus
Insulet Corporation develops, manufactures, and sells the Omnipod platform, a tubeless continuous insulin delivery system for people with insulin-dependent diabetes.
Outset Medical, Inc.
OM · Electromedical & Electrotherapeutic Apparatus
OBOOK Holdings Inc
OWLS · Services-Prepackaged Software
iWallet Corp
IWAL · Communications Equipment, NEC
iWallet Corp is a U.S.-based company focused on designing and developing biometric locking wallets and related personal security products.
Ibotta, Inc.
IBTA · Services-Advertising
Inogen Inc
INGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Inogen Inc designs, markets, and sells portable and stationary oxygen concentrators and related respiratory products for people needing long-term oxygen therapy.
Last updated: 24/09/2026